KFRE: Validated Risk Prediction Tool for Kidney Replacement Therapy
KFRE, a validated risk prediction tool, aids in predicting the need for kidney replacement therapy in adults with chronic kidney disease. Developed in Canada in 2011, KFRE has undergone validation in over 30 countries, showing superior clinical accuracy in KRT prediction. Caution is advised when usi
0 views • 9 slides
Detection of Mutations in EGFR in Circulating Lung Cancer Cells: Study on SARMS Assay and CTC-Chip
This study by Shyamala Maherswaran, Ph.D., and team focuses on characterizing mutations in EGFR in circulating tumor cells using SARMS assay and CTC-chip. The research investigates the effectiveness of these non-invasive methods in analyzing tumors and explores the role of the T790M mutation in resp
0 views • 12 slides